Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary study objective is to evaluate the efficacy of Lanreotide Autogel (ATG) 120 mg in combination with Temozolomide in patients with functioning as well as non-functioning, progressive, gastro-entero-pancreatic NET G1 or G2.
Critère d'inclusion
- metastatic functioning and non-functioning entero-pancreatic tumours